As for TP53, its transcript level, mutation status, spectra, or functional classifications were not significantly associated with any of the clinical parameters (age, stage, grade of tumor, subtype, surgical radicality, chemosensitivity status, or OS, all p > .05). This evidence concerns the gene TP53 and neoplasm.